• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HIN
Click for more information
0.00% $2.37

HEARTWARE INTERNATIONAL, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HINRemoval from Official List at close 17/09/201317/09/13
HINASX Appendix 3B - Options Exercise17/09/13
HINASX Appendix 3B - Options Grant17/09/13
HINSuspension from Official Quotation - Close of trading 10/09PRICE SENSITIVE10/09/13
HINOptions Exercise - ASX Appendix 3B09/09/13
HINChange of Director's Interest Notice09/09/13
HINUS FDA Grants HeartWare Full Approval for Protocol to SupplePRICE SENSITIVE28/08/13
HINOptions Exercise - ASX Appendix 3B23/08/13
HINHeartWare to Webcast Presentation at Canaccord Genuity Growt12/08/13
HINAppendix 4D and Half Year Financial StatementPRICE SENSITIVE12/08/13
HINReports 2013 Q2 Rev of US$50.8M vs US$29.1M in Q2 2012PRICE SENSITIVE09/08/13
HINOptions Exercise - ASX Appendix 3B08/08/13
HINChange of Director's Interest Notice08/08/13
HINChange of Director's Interest Notice02/08/13
HINChange of Director's Interest Notice01/08/13
HINOptions Exercise - ASX Appendix 3B30/07/13
HINNotice of Second Quarter Financial Results Call19/07/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation16/07/13
HINOptions Exercise - ASX Appendix 3B09/07/13
HINChange of Director's Interest Notice03/07/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation03/07/13
HINASX Appendix 3B - Options Exercise and Cancellation26/06/13
HINASX Appendix 3B - Options Exercise and Cancellation19/06/13
HINASX Delisting - Letter to CDI Holders19/06/13
HINUS FDA Grants Conditional Approval to Enroll Supplemental CoPRICE SENSITIVE18/06/13
HINHeartWare to Webcast Presentation at Wells Fargo Healthcare13/06/13
HINHeartWare to Delist from Australian Securities ExchangePRICE SENSITIVE13/06/13
HINChange of Director's Interest Notice11/06/13
HINChange of Director's Interest Notice06/06/13
HINHeartWare to Webcast Presentation at Goldman Sachs Global He06/06/13
HINChange of Director's Interest Notices04/06/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation04/06/13
HINChange of Director's Interest Notice31/05/13
HINChange of Director's Interest Notice31/05/13
HINChange of Director's Interest Notice31/05/13
HINOptions Exercise - ASX Appendix 3B31/05/13
HINASX Appendix 3B - Grant of Options30/05/13
HINAnnual General Meeting Results22/05/13
HINAnnual General Meeting/Chairman's Address22/05/13
HINASX Appendix 3B - Options Vesting and Exercise21/05/13
HINChange of Director's Interest Notices20/05/13
HINHeartWare to Webcast Presentation at UBS Global Healthcare C17/05/13
HINASX Appendix 3B - Options vesting and exercise10/05/13
HINFirst Quarter 2013 Financial Results07/05/13
HINReports 2013 Q1 Rev of US$49.2M vs US$26.4M in Q1 2012PRICE SENSITIVE30/04/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation23/04/13
HINNotice of Annual General Meeting16/04/13
HINASX Appendix 3B - Options Vesting and Exercise27/03/13
HINChange of Director's Interest Notice21/03/13
HINCapital Raising - ASX Appendix 3B Allotment19/03/13
HINCapital Raising - Cleansing Notice19/03/13
HINHeartWare Announces Closing of Public Offering19/03/13
HINOptions Exercise - ASX Appendix 3B19/03/13
HINASX Appendix 3B - Options Exercise15/03/13
HINProspectus Supplement for Public Offering of Common Stock15/03/13
HINProspectus for Public Offering of HeartWare Common StockPRICE SENSITIVE14/03/13
HINPricing of Public Offering of Common StockPRICE SENSITIVE13/03/13
HINHeartWare Announces Public Offering of Common StockPRICE SENSITIVE12/03/13
HINASX Appendix 3B - Grant and Cancellation of Options11/03/13
HINASX Appendix 3B - Options Grant11/03/13
HINHeartWare to Webcast Presentation at Barclays Capital Global07/03/13
HINHeartWare to Webcast Presentation at Raymond James Conferenc01/03/13
HINAnnual Report for 2012 and ASX Appendix 4EPRICE SENSITIVE28/02/13
HINReports 2012 Revenue of US$110.9M vs US$82.8M in 2011PRICE SENSITIVE28/02/13
HINNotice of Fourth Quarter Financial Results Call19/02/13
HINGrant of Incentive Equity - ASX Appendix 3B18/02/13
HINHeartWare to webcast presentation at Leerink Swann Global He11/02/13
HINHeartWare Initiates Voluntary Field Correction Advising Insp11/02/13
HINAmended Change of Director's Interest Notice23/01/13
HINChange of Director's Interest Notice22/01/13
HINASX Appendix 3B16/01/13
HINASX Appendix 3B - Grant and Cancellation of Options10/01/13
HINHeartWare Announces Preliminary Q4 2012 Revenues of US$32MilPRICE SENSITIVE08/01/13
HINAmended Change of Director's Interest Notice04/01/13
HINHeartWare to Webcast Presentation at JP Morgan Healthcare Co04/01/13
HINASX Appendix 3B - Options Exercise and Vesting02/01/13
HINChange of Director's Interest Notice02/01/13
HINASX Appendix 3B - Options Exercise21/12/12
HINChange of Director's Interest Notice21/12/12
HINChange of Director's Interest Notice17/12/12
HINOptions Exercise and Vesting - ASX Appendix 3B12/12/12
HINHeartWare to Webcast Presentation at Oppenheimer Healthcare06/12/12
HINChange of Director's Interest Notice06/12/12
HINASX Appendix 3B - Options Exercise and Cancellation06/12/12
HINOptions Vesting, Exercise and Expiration - ASX Appendix 3B27/11/12
HINChange of Director's Interest Notice27/11/12
HINHeartWare Receives U.S. FDA Approval For HVAD PumpPRICE SENSITIVE21/11/12
HINHeartWare to Webcast Presentation at Piper Jaffray Healthcar20/11/12
HINSupplemental Financial Information for Q1 201216/11/12
HINHeartWare to Webcast Presentation at Lazard Healthcare Confe12/11/12
HINThird Quarter 2012 Financial Results12/11/12
HINReports 2012 Q3 Rev of US$ 22.9 M vs. US$ 21.3 M in 2011 Q3PRICE SENSITIVE12/11/12
HINNotice of Third Quarter Financial Results Call02/11/12
HINOption Exercise - ASX Appendix 3B23/10/12
HINHeartWare to Withdraw Participation in Pilot Study Revive-ItPRICE SENSITIVE16/10/12
HINASX Appendix 3B - Options Exercise and Options Cancellation28/09/12
HINASX Appendix 3B - Options Grant26/09/12
HINASX Appendix 3B - Options Exercise24/09/12
HINChange of Director's Interest Notice24/09/12
HINHeartWare to Webcast Presentation at UBS Global Life Science17/09/12
HINRemoval from Official List at close 17/09/2013
17/09/13
HINASX Appendix 3B - Options Exercise
17/09/13
HINASX Appendix 3B - Options Grant
17/09/13
HINSuspension from Official Quotation - Close of trading 10/09
10/09/13PRICE SENSITIVE
HINOptions Exercise - ASX Appendix 3B
09/09/13
HINChange of Director's Interest Notice
09/09/13
HINUS FDA Grants HeartWare Full Approval for Protocol to Supple
28/08/13PRICE SENSITIVE
HINOptions Exercise - ASX Appendix 3B
23/08/13
HINHeartWare to Webcast Presentation at Canaccord Genuity Growt
12/08/13
HINAppendix 4D and Half Year Financial Statement
12/08/13PRICE SENSITIVE
HINReports 2013 Q2 Rev of US$50.8M vs US$29.1M in Q2 2012
09/08/13PRICE SENSITIVE
HINOptions Exercise - ASX Appendix 3B
08/08/13
HINChange of Director's Interest Notice
08/08/13
HINChange of Director's Interest Notice
02/08/13
HINChange of Director's Interest Notice
01/08/13
HINOptions Exercise - ASX Appendix 3B
30/07/13
HINNotice of Second Quarter Financial Results Call
19/07/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation
16/07/13
HINOptions Exercise - ASX Appendix 3B
09/07/13
HINChange of Director's Interest Notice
03/07/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation
03/07/13
HINASX Appendix 3B - Options Exercise and Cancellation
26/06/13
HINASX Appendix 3B - Options Exercise and Cancellation
19/06/13
HINASX Delisting - Letter to CDI Holders
19/06/13
HINUS FDA Grants Conditional Approval to Enroll Supplemental Co
18/06/13PRICE SENSITIVE
HINHeartWare to Webcast Presentation at Wells Fargo Healthcare
13/06/13
HINHeartWare to Delist from Australian Securities Exchange
13/06/13PRICE SENSITIVE
HINChange of Director's Interest Notice
11/06/13
HINChange of Director's Interest Notice
06/06/13
HINHeartWare to Webcast Presentation at Goldman Sachs Global He
06/06/13
HINChange of Director's Interest Notices
04/06/13
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation
04/06/13
HINChange of Director's Interest Notice
31/05/13
HINChange of Director's Interest Notice
31/05/13
HINChange of Director's Interest Notice
31/05/13
HINOptions Exercise - ASX Appendix 3B
31/05/13
HINASX Appendix 3B - Grant of Options
30/05/13
HINAnnual General Meeting Results
22/05/13
HINAnnual General Meeting/Chairman's Address
22/05/13
HINASX Appendix 3B - Options Vesting and Exercise
21/05/13
HINChange of Director's Interest Notices
20/05/13
HINHeartWare to Webcast Presentation at UBS Global Healthcare C
17/05/13
HINASX Appendix 3B - Options vesting and exercise
10/05/13
HINFirst Quarter 2013 Financial Results
07/05/13
HINReports 2013 Q1 Rev of US$49.2M vs US$26.4M in Q1 2012
30/04/13PRICE SENSITIVE
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation
23/04/13
HINNotice of Annual General Meeting
16/04/13
HINASX Appendix 3B - Options Vesting and Exercise
27/03/13
HINChange of Director's Interest Notice
21/03/13
HINCapital Raising - ASX Appendix 3B Allotment
19/03/13
HINCapital Raising - Cleansing Notice
19/03/13
HINHeartWare Announces Closing of Public Offering
19/03/13
HINOptions Exercise - ASX Appendix 3B
19/03/13
HINASX Appendix 3B - Options Exercise
15/03/13
HINProspectus Supplement for Public Offering of Common Stock
15/03/13
HINProspectus for Public Offering of HeartWare Common Stock
14/03/13PRICE SENSITIVE
HINPricing of Public Offering of Common Stock
13/03/13PRICE SENSITIVE
HINHeartWare Announces Public Offering of Common Stock
12/03/13PRICE SENSITIVE
HINASX Appendix 3B - Grant and Cancellation of Options
11/03/13
HINASX Appendix 3B - Options Grant
11/03/13
HINHeartWare to Webcast Presentation at Barclays Capital Global
07/03/13
HINHeartWare to Webcast Presentation at Raymond James Conferenc
01/03/13
HINAnnual Report for 2012 and ASX Appendix 4E
28/02/13PRICE SENSITIVE
HINReports 2012 Revenue of US$110.9M vs US$82.8M in 2011
28/02/13PRICE SENSITIVE
HINNotice of Fourth Quarter Financial Results Call
19/02/13
HINGrant of Incentive Equity - ASX Appendix 3B
18/02/13
HINHeartWare to webcast presentation at Leerink Swann Global He
11/02/13
HINHeartWare Initiates Voluntary Field Correction Advising Insp
11/02/13
HINAmended Change of Director's Interest Notice
23/01/13
HINChange of Director's Interest Notice
22/01/13
HINASX Appendix 3B
16/01/13
HINASX Appendix 3B - Grant and Cancellation of Options
10/01/13
HINHeartWare Announces Preliminary Q4 2012 Revenues of US$32Mil
08/01/13PRICE SENSITIVE
HINAmended Change of Director's Interest Notice
04/01/13
HINHeartWare to Webcast Presentation at JP Morgan Healthcare Co
04/01/13
HINASX Appendix 3B - Options Exercise and Vesting
02/01/13
HINChange of Director's Interest Notice
02/01/13
HINASX Appendix 3B - Options Exercise
21/12/12
HINChange of Director's Interest Notice
21/12/12
HINChange of Director's Interest Notice
17/12/12
HINOptions Exercise and Vesting - ASX Appendix 3B
12/12/12
HINHeartWare to Webcast Presentation at Oppenheimer Healthcare
06/12/12
HINChange of Director's Interest Notice
06/12/12
HINASX Appendix 3B - Options Exercise and Cancellation
06/12/12
HINOptions Vesting, Exercise and Expiration - ASX Appendix 3B
27/11/12
HINChange of Director's Interest Notice
27/11/12
HINHeartWare Receives U.S. FDA Approval For HVAD Pump
21/11/12PRICE SENSITIVE
HINHeartWare to Webcast Presentation at Piper Jaffray Healthcar
20/11/12
HINSupplemental Financial Information for Q1 2012
16/11/12
HINHeartWare to Webcast Presentation at Lazard Healthcare Confe
12/11/12
HINThird Quarter 2012 Financial Results
12/11/12
HINReports 2012 Q3 Rev of US$ 22.9 M vs. US$ 21.3 M in 2011 Q3
12/11/12PRICE SENSITIVE
HINNotice of Third Quarter Financial Results Call
02/11/12
HINOption Exercise - ASX Appendix 3B
23/10/12
HINHeartWare to Withdraw Participation in Pilot Study Revive-It
16/10/12PRICE SENSITIVE
HINASX Appendix 3B - Options Exercise and Options Cancellation
28/09/12
HINASX Appendix 3B - Options Grant
26/09/12
HINASX Appendix 3B - Options Exercise
24/09/12
HINChange of Director's Interest Notice
24/09/12
HINHeartWare to Webcast Presentation at UBS Global Life Science
17/09/12
refresh Created with Sketch. REFRESH
 

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.